UBS Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.1M | Sell |
143,525
-16,070
| -10% | -$4.28M | 0.01% | 1940 |
|
|
2025
Q4 | $39.3M | Buy |
159,595
+29,422
| +23% | +$6.19M | 0.01% | 1879 |
|
|
2025
Q3 | $23M | Buy |
130,173
+32,933
| +34% | +$4.93M | ﹤0.01% | 2403 |
|
|
2025
Q2 | $13.4M | Buy |
97,240
+16,121
| +20% | +$2.37M | ﹤0.01% | 2800 |
|
|
2025
Q1 | $14.6M | Sell |
81,119
-19,012
| -19% | -$3.2M | ﹤0.01% | 2652 |
|
|
2024
Q4 | $15.7M | Buy |
100,131
+63,802
| +176% | +$11.3M | ﹤0.01% | 2595 |
|
|
2024
Q3 | $6.61M | Buy |
36,329
+7,773
| +27% | +$1.5M | ﹤0.01% | 2777 |
|
|
2024
Q2 | $5.24M | Sell |
28,556
-22,472
| -44% | -$3.77M | ﹤0.01% | 2840 |
|
|
2024
Q1 | $9.08M | Buy |
51,028
+20,268
| +66% | +$2.82M | ﹤0.01% | 2355 |
|
|
2023
Q4 | $3.82M | Buy |
+30,760
| New | +$3.41M | ﹤0.01% | 3067 |
|
|
2023
Q3 | – | Sell |
-11,217
| Closed | -$1.32M | – | 9734 |
|
|
2023
Q2 | $1.32M | Sell |
11,217
-16,911
| -60% | -$1.73M | ﹤0.01% | 3974 |
|
|
2023
Q1 | $2.25M | Sell |
28,128
-14,495
| -34% | -$1.14M | ﹤0.01% | 3292 |
|
|
2022
Q4 | $3.38M | Buy |
42,623
+42,459
| +25,890% | +$3.15M | ﹤0.01% | 2860 |
|
|
2022
Q3 | $11K | Sell |
164
-15,670
| -99% | -$1.13M | ﹤0.01% | 8304 |
|
|
2022
Q2 | $1.04M | Sell |
15,834
-42,236
| -73% | -$2.63M | ﹤0.01% | 3711 |
|
|
2022
Q1 | $3.86M | Buy |
58,070
+56,237
| +3,068% | +$3.51M | ﹤0.01% | 2789 |
|
|
2021
Q4 | $128K | Sell |
1,833
-21,490
| -92% | -$1.25M | ﹤0.01% | 6075 |
|
|
2021
Q3 | $1.22M | Buy |
23,323
+21,315
| +1,062% | +$1.26M | ﹤0.01% | 4015 |
|
|
2021
Q2 | $137K | Sell |
2,008
-35,379
| -95% | -$2.47M | ﹤0.01% | 5629 |
|
|
2021
Q1 | $2.88M | Buy |
37,387
+23,258
| +165% | +$1.69M | ﹤0.01% | 3186 |
|
|
2020
Q4 | $848K | Buy |
14,129
+2,192
| +18% | +$109K | ﹤0.01% | 4150 |
|
|
2020
Q3 | $514K | Buy |
11,937
+11,666
| +4,305% | +$507K | ﹤0.01% | 4173 |
|
|
2020
Q2 | $11K | Sell |
271
-16,539
| -98% | -$796K | ﹤0.01% | 6948 |
|
|
2020
Q1 | $727K | Buy |
16,810
+5,636
| +50% | +$295K | ﹤0.01% | 3637 |
|
|
2019
Q4 | $619K | Sell |
11,174
-21,394
| -66% | -$1.05M | ﹤0.01% | 4645 |
|
|
2019
Q3 | $1.13M | Buy |
32,568
+31,843
| +4,392% | +$1.42M | ﹤0.01% | 3861 |
|
|
2019
Q2 | $29K | Buy |
+725
| New | +$23.7K | ﹤0.01% | 6357 |
|
|
2019
Q1 | – | Sell |
-675
| Closed | -$14K | – | 7948 |
|
|
2018
Q4 | $14K | Buy |
+675
| New | +$14.1K | ﹤0.01% | 7042 |
|
|
2017
Q4 | – | Sell |
-2,562
| Closed | -$26K | – | 7979 |
|
|
2017
Q3 | $26K | Buy |
+2,562
| New | +$25.8K | ﹤0.01% | 6269 |
|
Other funds holding KRYS
ACA
VPM
VCM
SCM
RG